Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Ron Byron Netherlands

Cell4Pharma BV is a Dutch Bio-tech company that produces and commercializes human renal proximal tubule epithelial cell lines to perform in vitro toxicology assessments, with the aim to eliminate renal toxicity for compounds entering clinical stages of drug development; Cell4Pharma aims to lower drug failure during the clinical phase of drug development due to kidney toxicity.
To get more successful drugs to market, we empower researchers to accurately identify and eliminate nephro-toxic compounds during preclinical stages of drug development. We partner with CRO's to deliver our highly accurate and stable human renal ciPTEC Cell Lines to researchers of Bio-pharmaceutical companies and Academia
Website:
https://cell4pharma.com
Year of foundation
2017
Looking for
Please specify your partnering goal
We are searching for CRO's as strategic partners in China to deliver our assay ready ciPTEC Cell Lines to researchers of Bio-pharmaceutical companies and Academia in China
Headquartner in China
No
Plan in China
Identify a strategic partner; commercialize and role-out our assay ready ciPTEC Cell Lines
Assets Information 1: Name|Description|Indications|Stage|IP countries
Human Renal Cell lines|human renal proximal tubule epithelial cell lines to perform in vitro toxicology assessments,|Toxicology testing|Ready to commercialize|Global license
Cell4Pharma BV
CEO 
Functionality
Management